Navigation Links
Ambrx Appoints Douglas Axelrod Senior Vice President for Clinical Research and Development
Date:2/26/2008

SAN DIEGO, Feb. 26 /PRNewswire/ -- Ambrx Inc. today announced the appointment of Douglas W. Axelrod, M.D., Ph.D., as Senior Vice President for Clinical Research and Development.

Axelrod joins Ambrx after a productive career spanning nearly two decades at Procter & Gamble Pharmaceuticals. Most recently, he served as Vice President of R&D for Discovery, Early Development and Product Development where he accelerated the discovery process, improved the discovery to early development transition and led efficiencies in product development. Earlier in his career, Axelrod led the P&G Worldwide Clinical Bone group, stewarding drugs such as Didronel(TM) and Actonel(TM) through late clinical development and regulatory approvals. These drugs became among the leading osteoporosis therapies worldwide. Axelrod obtained his doctorate in the Department of Cell Biology at Baylor College of Medicine. He obtained his medical degree at the same institution, where he completed his Residency in Internal Medicine, Fellowship in Endocrinology and Metabolism and served as Visiting Scientist in the Department of Cell Biology at MD Anderson Tumor Institute.

"Doug has tremendous depth and breadth of experience in drug discovery and development and has been successful in delivering innovative medicines to patients," said Steve Kaldor, Ph.D., Ambrx's President and CEO. "He will be integral to the ongoing build out of Ambrx's development capabilities in support of our rapidly maturing pipeline of clinical and preclinical phase protein drug candidates."

Axelrod added: "I am pleased and excited to join Ambrx at this exciting stage of its development. The company has moved rapidly from proof of concept of the ReCODE(TM) technologies to the creation and development of a family of important and practical biologics-based products. I look forward to playing a role in bringing these important products to clinical reality and into the marketplace, both with our collaborators and
'/>"/>

SOURCE Ambrx Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
2. Codexis Appoints Singapore Laboratories Managing Director
3. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
4. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
5. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
6. NanoLogix Inc. Appoints Director of IP and Makes Progress on Rapid Anthrax Detection
7. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
8. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
9. NeurogesX Appoints New Director to the Board
10. Alba Therapeutics Appoints Dr. Betsy Van Parijs as Its Senior Vice President, Clinical Development and Medical Affairs
11. Premier Research Appoints Melissa Jones as Vice President, International Business Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... 2015  StemProtein LLC, a leading manufacturer of ... Stemedica Cell Technologies Inc., announced today that it ... of StemProtein. Silberg will help advance the Company,s ... Cell Factors (SCFs), a significant consumer opportunity. ... and biopharmaceutical industries with substantial executive level experience ...
(Date:9/3/2015)... ... 2015 , ... Michigan-based technology startup Halo Wearables ... The device, called the Halo H1, is a wearable that monitors the user’s ... track trending interstitial fluid levels in the body, in addition to sodium-potassium ratios ...
(Date:9/2/2015)... 2, 2015 Research and Markets ... of Jain PharmaBiotech,s new report "Nanobiotechnology ... offering. An increasing use ... industries is anticipated. Nanotechnology will be applied ... from formulations for optimal delivery to diagnostic ...
(Date:9/2/2015)... 02, 2015 Research ... addition of Jain PharmaBiotech,s new report "Biochips ... to their offering. This report is ... and applications. The report starts with a description ... markets. Technologies include array comparative genomic hybridization (CGH), ...
Breaking Biology Technology:StemProtein Names Thomas H. Silberg As CEO, To Focus On Stem Cell Secreted Proteins Addresing A Variety Of Health And Beauty Related Needs 2StemProtein Names Thomas H. Silberg As CEO, To Focus On Stem Cell Secreted Proteins Addresing A Variety Of Health And Beauty Related Needs 3Technology Startup Halo Wearables to Unveil Non-Invasive Hydration Monitoring Device Early 2016 2Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 2Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 3Global Biochips and Microarrays Technologies, Markets and Companies Report 2015 with Market Size in 2014 and Projected Value for the Years 2019 and 2024 2
... Corporation adds advanced cholesterol testing capabilities, ... a,cardio-diagnostic company, today announced that its VAP(R) ... newly released health,assessment, BiophysicalCheck., The announcement ... unique ability to,identify far more areas of ...
... 31 InNexus,Biotechnology Inc., (TSX VENTURE: IXS; ... drug development company commercializing the,next generation of ... Linking,(DXL(TM)) technology, will present at IBC,s 13th ... Innovative Therapeutics (DDT) Conference being,held in Boston ...
... Alsius Corporation,(Nasdaq: ALUS ), the worldwide ... ill patients, today,announced that it will hold a ... and provide a corporate update. Bill Worthen,president and ... p.m. Pacific Time,(4:30 p.m. Eastern Time) on Thursday, ...
Cached Biology Technology:VAP(R) Cholesterol Test Bolsters Biophysical(R) Health Assessment 2VAP(R) Cholesterol Test Bolsters Biophysical(R) Health Assessment 3InNexus Biotechnology CEO and Chief Scientific Officer to Present at IBC's Annual World Congress Conference in Boston on Aug 6th 2Alsius Corporation to Host Second Quarter 2008 Financial Results Conference Call on August 7 2
(Date:8/20/2015)... ., Aug. 20, 2015 NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce market ... has joined The Smart Card Alliance and the EMV ... Alliance and the Smart Card Alliance Latin America (SCALA) ... industry peers and thought leaders promoting adoption of smart ...
(Date:8/12/2015)... MINNETONKA, Minn. , Aug. 12, 2015   ... that supports the entire spectrum of clinical research, is ... ™ , the company,s comprehensive SaaS-based eClinical technology platform, ... growth during the first two quarters of 2015.   ... and second largest quarters measured by contract value sold ...
(Date:8/10/2015)... Germany , August 10, 2015 ... in Eye Tracking Technology for more than two decades, ... Platform for integration into all consumer display formats. The ... seamless integration of eye tracking into consumer tablets, laptops, ... reality smart glasses. Omnivision,s leading sensor technology contributes to ...
Breaking Biology News(10 mins):NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 2NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 3NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 4MedNet Solutions Experiences Explosive Corporate Growth 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3
... A female moth sitting on a goal post could attract ... And even if she switched her scent over time, the male ... gene in his antenna. A team of researchers led by ... how it adapted to even the slightest change in the chemicals ...
... -- Tissue implants made of cells grown on a ... help heal arteries scarred by atherosclerosis and other vascular ... work better than others. MIT researchers led by ... Professor of Health Sciences and Technology, have now shown ...
... and his colleagues have received a National Institutes of Health ... most basic messaging system affect cellular processes. ... will receive more than a million dollars over five years ... cells. The goal is to create techniques to generate and ...
Cached Biology News:Team discovers reason that male moths can keep finding females 2Team discovers reason that male moths can keep finding females 3Success of engineered tissue depends on where it's grown 2Success of engineered tissue depends on where it's grown 3NIH backs Rice University study of delay in gene transcription networks 2
... Dish uses include large-scale colony-counting and plaque-lifting, ... Flexys TM automated colony picking and ... new product number, created to easily match ... yet, please order under the old Sigma-Aldrich ...
BD BioCoat Collagen IV 150 mm Culture Dishes...
Polymerase (RNA) II (DNA directed) polypeptide L...
Chicken Anti-Human DNA-directed RNA Polymerase II 7.6 Kd Polypeptide (POLR2L Polyclonal AntibodyOther Sub-Family: not assigned-Other Applications: ELISA, Western Blot...
Biology Products: